Market Forces Cited in Lymphoma Drugsâ Disuse
171088
Only about 10 percent of people who are suitable candidates for two drugs received one of them last year.
49823
After years of struggling to make anti-retrovirals available in the developing world, medical authorities have been startled to discover that many people in the advanced stages of AIDS are reluctant to take them -- or accept the treatment only when death is so near that the medication can no longer reverse the slide.
212028
Drug companies rushing to fill the vacuum left by Merck &amp; Co.&#39;s withdrawal of its best-selling arthritis drug Vioxx are flooding the airwaves with competing
133867
The arthritis drug Vioxx, used by millions of people around the world, is being pulled off the market after a study confirmed long-standing concerns that it raises
20326
When a great launch of a good drug is not enough.
330991
Doctors are missing key information they need to make decisions for cancer patients because some drug companies are not publishing clinical trials.
719234
US Food and Drug Administration staff reviewers on Tuesday questioned clinical data for non-Hodgkin&#39;s lymphoma drug Marqibo, made by Inex Pharmaceuticals Corp.
333713
Investors' fear that drug prices will be hurt under a Kerry presidency has sent the stocks of many pharmaceutical companies lower.
121
While the FDA contends otherwise, new data show that sales of the antidepressants known as SSRIÂs have declined.
550204
CHICAGO/NEW YORK  - When it comes to the price tag  for the newest biotechology drugs for cancer and other  hard-to-treat diseases, the sky is likely to remain the limit,  insurers, drugmakers and industry watchers say.
579715
NEW YORK  - About half of the patients in  the US with aggressive non-Hodgkin's lymphoma, (NHL), cancer of  the lymph glands, are not receiving the full dose of  chemotherapy that is recommended, investigators report in the  Journal of Clinical Oncology.
161619
The fight over the lucrative market for rheumatoid arthritis drugs is heating up. In the last five years, three similar drugs have been introduced that offer patients the promise of getting back on their feet. Now the manufacturers of all three are jockeying for market share so they can be the leader when Medicare's full prescription drug benefit takes effect ...
452827
The federal Food and Drug Administration&#39;s ability to protect the American public is in question in the wake of the problems with this year&#39;s flu vaccine shortage and claims that it is allowing unsafe drugs to remain on the market.
403607
THE pharmaceutical industry was reeling last night, as AstraZeneca and Pfizer put key drug development programmes on hold and Eli Lilly issued a warning on one of its best selling medicines.
500550
MONDAY, Dec. 11 (HealthDay News) -- A combination of three chemotherapy drugs -- pentostatin, cyclophosphamide and rituximab --  produced significant clinical response in patients with previously untreated chronic lymphocytic leukemia, according to a study presented Sunday at the American Society of Hematology annual meeting.
427064
Remicade, a Johnson &amp; Johnson rheumatoid arthritis drug may increase the risk of developing of lymphoma, a blood cancer, the company announced today.
100064
Research and development costs drag down the drug developer's bottom line.